For research use only. Not for therapeutic Use.
Ergoloid mesylates (CAT: I004938) are a mixture of alkaloid derivatives derived from ergot fungi. These compounds have pharmacological actions that are not fully understood, but they are believed to have a modulatory effect on various neurotransmitter systems in the brain, including dopamine, serotonin, and norepinephrine. Ergoloid mesylates have been used in the treatment of age-related cognitive decline, dementia, and related conditions. They are thought to enhance cognitive function, improve memory, and increase cerebral blood flow. The precise mechanisms of action are complex and multifaceted, involving interactions with multiple receptors and neurotransmitter systems. Further research is needed to fully elucidate the therapeutic potential of ergoloid mesylates in various neurological conditions.
Catalog Number | I004938 |
CAS Number | 8067-24-1 |
Synonyms | (6aR,9R,10aR,Z)-N-((S)-1-hydroxypropan-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carbimidic acid compound with methanesulfonic acid (1:1); Dihydroergotoxine monomethanesulfonate (salt); An equiproportional mixture of dihydroergocornine of mesylate, dihydroergocristine mesylate, and ratio of dihydro-a-ergocryptine mesylate to dihydro-b-ergocryptine mesylate is (1.5-2.5:1) |
Molecular Formula | C20H29N3O5S |
Purity | ≥95% |
Target | GABA Receptor |
Solubility | DMSO: ≥ 31 mg/mL |
Storage | Store at RT |
Reference | <p style=”/line-height:25px/”> |